RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Est. Return 25.98%
This Quarter Est. Return
1 Year Est. Return
+25.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.74B
AUM Growth
+$171M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
140
New
Increased
Reduced
Closed

Top Buys

1
+$47.6M
2
+$29.2M
3
+$29M
4
CHRS icon
Coherus Oncology
CHRS
+$26.7M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$15.1M

Top Sells

1
+$29M
2
+$16.4M
3
+$15.1M
4
IFRX icon
InflaRx
IFRX
+$8.5M
5
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$7.18M

Sector Composition

1 Healthcare 86.9%
2 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$19.2M 0.69%
550,000
+136,600
52
$19.1M 0.69%
950,000
+120,000
53
$18.7M 0.68%
1,423,256
+283,256
54
$18.4M 0.67%
1,562,300
+2,300
55
$18M 0.65%
790,000
+325,000
56
$17.5M 0.63%
404,000
57
$17.2M 0.62%
137,500
+12,500
58
$17.1M 0.62%
185,150
59
$16.9M 0.61%
92,500
60
$16.7M 0.61%
242,000
61
$16.4M 0.59%
190,000
+10,000
62
$16.4M 0.59%
400,000
63
$15.8M 0.57%
430,000
-15,000
64
$15.5M 0.56%
410,000
-112,500
65
$15M 0.54%
343,500
+83,500
66
$13.9M 0.5%
265,000
+20,000
67
$13.8M 0.5%
12,240
68
$13.7M 0.49%
182,800
69
$12.7M 0.46%
1,009,179
70
$12.7M 0.46%
195,500
+160,800
71
$12.7M 0.46%
1,120,000
72
$12.5M 0.45%
1,000,000
73
$12.4M 0.45%
895,000
+95,000
74
$12.3M 0.45%
195,000
75
$12.3M 0.45%
218,500
+48,500
1 2
3
4 5